A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease

被引:14
|
作者
Jerkins, Gary [1 ]
Greiner, Jack, V [2 ,3 ]
Tong, Louis [4 ,5 ,6 ]
Tan, Jacqueline [7 ]
Tauber, Joseph [8 ]
Mearza, Ali [9 ,10 ]
Srinivasan, Sruthi [11 ]
机构
[1] Adv Vis Res LLC, Nashville, TN 37205 USA
[2] Clin & & Res Boston, Boston, MA USA
[3] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[4] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore, Singapore
[5] Singapore Eye Res Inst, Singapore, Singapore
[6] Duke Natl Univ, Singapore Med Sch, Singapore, Singapore
[7] Univ New South Wales, Sydney, NSW, Australia
[8] Tauber Eye Ctr, Kansas City, MO USA
[9] Imperial Coll Healthcare NHS Trust, London, England
[10] Ophthalm Consultants London, London, England
[11] Alcon Res LLC, Johns Creek, GA USA
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
dry eye; lipid-deficient; evaporative dry eye; lubricant eye drops; non-inferiority; ARTIFICIAL TEARS; MULTICENTER; DEFICIENT; EMULSION; LAYER;
D O I
10.2147/OPTH.S256351
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to compare the efficacy of two lipid-based lubricant eye drops in patients with lipid-deficient dry eye. Methods: This Phase IV, multicenter, prospective, double-masked study enrolled adults (aged >= 18 years) who had a tear film breakup time (TFBUT) of <= 15 seconds(s), and unanesthetized Schirmer I test of >= 3 mm to <= 12 mm in at least one eye, at both screening and baseline visits. Eligible patients (n=231) were randomized (1:1) and received either Systane (R) Balance (SYSB; n=117) or Refresh (R) Optive Advanced (RFO-Ad, n=114), four-times a day, for 35 days. The primary endpoint was non-inferiority for change from baseline in TFBUT at Day 35 (noninferiority was established if the lower limit of the 95% confidence interval (CI) for the difference between the treatment groups was > -1.0 s); secondary endpoints (test of superiority) were change in TFBUTand global ocular discomfort visual analog scale (VAS) score at Day 35. Other endpoints included the impact of dry eye on everyday life (IDEEL) treatment satisfaction scores (inconvenience and effectiveness) and safety. Results: At Day 35, themean change from baseline in TFBUTwas 0.998 s in the SYSB and 0.868 s in the RFO-Ad groups with a treatment difference: 0.130 s; (95% CI -0.34, 0.60; P<0.0001) demonstrating non-inferiority of SYSB to RFO-Ad. The global ocular discomfort VAS scores improved in both groups, with a mean change from baseline of -9.7 and -8.8 in SYSB and RFOAd groups (treatment difference -0.8; P=0.62), respectively. No meaningful difference was observed in IDEEL treatment effectiveness and treatment inconvenience scores between SYSB vs RFO-Ad (P>0.05 for treatment difference). Both treatments were well tolerated. Conclusion: SYSB lubricant eye drops were non-inferior to RFO-Ad for improvement in TFBUT in patients with lipid-deficient dry eye. Both lubricant eye drops improved TFBUT and ocular discomfort scores in patients with lipid-deficient dry eye.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 50 条
  • [1] Clinical Comparison of Lipid-based and Aqueous Lubricant Eye drops
    Simmons, Peter
    Carlisle, Cindy
    Shi, Genming
    Vehige, Joseph
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial
    Simmons, Peter A.
    Carlisle-Wilcox, Cindy
    Vehige, Joseph G.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 657 - 664
  • [3] Lipid-based eye drop formulations for the management of evaporative dry eyes
    Maulvi, Furqan A.
    Desai, Ditixa T.
    Kalaiselvan, Parthasarathi
    Dumpati, Srikanth
    Kuppusamy, Rajesh
    Masoudi, Simin
    Shah, Dinesh O.
    Willcox, Mark D. P.
    CONTACT LENS & ANTERIOR EYE, 2024, 47 (03):
  • [4] Relevance of Lipid-Based Products in the Management of Dry Eye Disease
    Garrigue, Jean-Sebastien
    Amrane, Mourad
    Faure, Marie-Odile
    Holopainen, Juha M.
    Tong, Louis
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (09) : 647 - 661
  • [5] Novel anti-evaporative lipid-based formulation for dry eye disease treatment
    Jantti, Janika
    Viitaja, Tuomo
    Sevon, Julia
    Lajunen, Tatu
    Puranen, Jooseppi
    Raitanen, Jan-Erik
    Viljanen, Mira
    Paananen, Riku
    Moilanen, Jukka
    Ekholm, Filip
    Ruponen, Marika
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [6] Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye
    Merayo-Lloves, Jesus
    Sanchez-Avila, Ronald M.
    Riestra, Ana C.
    Anitua, Eduardo
    Begona, Leire
    Orive, Gorka
    Fernandez-Vega, Luis
    OPHTHALMIC RESEARCH, 2016, 56 (02) : 68 - 73
  • [7] Dry Eye: Efficacy and Safety of Cyclosporine Eye Drops after 1
    Bitzer, Michaela
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (04) : 360 - 360
  • [8] The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms
    Korb, DR
    Scaffidi, RC
    Greiner, JV
    Kenyon, KR
    Herman, JP
    Blackie, CA
    Glonek, T
    Case, CL
    Finnemore, VM
    Douglass, T
    OPTOMETRY AND VISION SCIENCE, 2005, 82 (07) : 594 - 601
  • [9] Clinical Efficacy of an Oil-based Lubricant Eye Drop in Dry Eye Patients with Lipid Deficiency
    Labetoulle, M.
    Maurino, V.
    Ogundele, A.
    Rossi, G. C. M.
    Van der Meulen, I.
    Mrukwa-Kominek, E.
    Galarreta, D.
    Boehringer, D.
    Baudouin, C.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [10] Propylene Glycol and Hydroxypropyl Guar Nanoemulsion-Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease
    Srinivasan, Sruthi
    Williams, Ravaughn
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 3311 - 3326